Clinical Significance of Testosterone and Dihydrotestosterone Metabolism in Women
March 1996
in “
PubMed
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → Studysummary This article discusses the complexities of diagnosing hyperandrogenism in women and reviews potential treatments, such as antiandrogens and finasteride, but reports no new clinical findings.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discussed the clinical significance of testosterone and dihydrotestosterone (DHT) metabolism in women, particularly in the context of hyperandrogenism, which involves excess androgen production and its clinical manifestations. It highlighted the complexity of evaluating hyperandrogenism due to the varying roles of adrenal and ovarian sources of androgens. The study noted that increased enzyme 5 alpha-reductase activity in the skin could lead to increased androgen sensitivity, converting testosterone to DHT, a localized phenomenon without a generalized increase in enzyme activity. DHT is rapidly metabolized into other steroid metabolites. Antiandrogens were identified as effective treatments for cutaneous hyperandrogenism, and clinical trials were underway to assess the efficacy of finasteride, a 5 alpha-reductase inhibitor, for treating hirsutism and androgenetic alopecia.
